The Ordinary Lactic Acid 10% + HA is a chemical exfoliant that contains lactic acid and hyaluronic acid to help improve skin texture and promote a smoother, more radiant complexion. Here’s a description of the product:
The Lactic Acid 10% + HA serum from The Ordinary is a mild exfoliating treatment that is formulated to gently resurface the skin, revealing a brighter and more even-toned complexion.
Key features of the product may include:
- Lactic Acid: Lactic acid is an alpha hydroxy acid (AHA) derived from milk. It acts as an exfoliant by gently dissolving the bonds between dead skin cells, promoting their shedding and encouraging cell turnover. This can help to improve skin texture, reduce the appearance of fine lines and wrinkles, and even out skin tone.
- Mild Exfoliation: The 10% concentration of lactic acid in this serum provides a gentle exfoliation that is suitable for most skin types, including sensitive skin. It helps to remove dull, dead skin cells, revealing a smoother and more radiant complexion.
- Hyaluronic Acid: The serum also contains hyaluronic acid (HA), which is a moisturizing ingredient that helps to hydrate and plump the skin. This can contribute to a more youthful and supple appearance.
- Enhanced Absorption: The presence of hyaluronic acid in the serum helps to enhance the absorption of lactic acid and aids in maintaining the skin’s hydration levels during the exfoliation process.
To use the product, you would typically apply a few drops of the serum to cleansed, dry skin in the evening. Gently massage it into the skin, avoiding the eye area. It is important to follow up with a moisturizer and apply sunscreen during the day, as AHAs can increase the skin’s sensitivity to the sun.
As with any exfoliating product, it’s recommended to start with a lower concentration and gradually increase usage to allow your skin to acclimate. It’s also advisable to perform a patch test before using the product, especially if you have sensitive skin or are new to chemical exfoliation.
Reviews
There are no reviews yet.